Leung Gabriel - Jun 7, 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Director
Signature
By: /s/ Steven Robbins, Attorney in Fact for Kinyip Gabriel Leung
Stock symbol
NVCR
Transactions as of
Jun 7, 2021
Transactions value $
-$173,100
Form type
4
Date filed
6/8/2021, 04:49 PM
Next filing
Jun 11, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $31.5K +1K +1.39% $31.45 73K Jun 7, 2021 Direct
transaction NVCR Ordinary Shares Sale -$205K -1K -1.37% $204.55* 72K Jun 7, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -1K -18.71% $0.00 4.35K Jun 7, 2021 Ordinary Shares 1K $31.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.
F2 Fully vested as of the date hereof.